InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Monday, 01/31/2022 10:00:07 AM

Monday, January 31, 2022 10:00:07 AM

Post# of 426858
Their last tweet was 19 days ago.

If I was them, I would tweet daily.

What would I tweet about?

• There is an unlimited amount of CVD data available. Cite statistics, make it relatable to the reader.

• Same with REDUCE-IT trial data, plenty of cute little DYKs (did you know) statistics, also make it relatable to the real world.

• Any news pertaining to IPE, such as the announcement of the ACC-22 presentations.

• Keep making it known that Vascepa's CVD indication is patented.

All the above are facts and should not be subject to FDA regulation.


These guys are squandering this free and easy opportunity to raise awareness and promote Vascepa.

And before someone gives counter argument, that this would help Generics ... who cares, as long as it helps Amarin. If Amarin spends money on the salesforce in the USA, why aren't they taking advantage of FREE Twitter?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News